New knowledge on genetic risk factors and targets for intervention in Parkinson’s disease

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

  1. Sidransky E, et al. N Engl J Med. 2009 Oct 22;361(17):1651-61.
  2. Blauwendraat C, et al. Brain. 2020;143:234–48.
  3. Aflaki E, et al. Neuron. 2017;93:737–46.
  4. Singleton A, Hardy J. Neuron. 2016;90:1154–63.
  5. Dusonchet J Neurosci. 2011;31:907–12.
  6. Pischedda F, et al. bioRxiv. 2020. doi:
  7. Cogo S, et al. J Neurochem. 2020;152:273–83.
  8. San Luciano M, et al. Mov Dis. 2020;35:1755–64.
  9. Van Diggelen F, et al. PLoS One. 2019;14(3):e0213663.
  10. Goedert M, et al. Nat Rev Neurol. 2013;9:13–24.
  11. Alam P, et al. J Neurochem. 2019;150:522–34.
  12. Van Diggelen F, et al. Isr J Chem. 2016;57:699–723.
Du lämnar Progress in Mind Sverige
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
Den här informationen är endast avsedd för hälso- och sjukvårdspersonal
Register for access to Progress in Mind in your country